Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Haselmann, VerenaÖzçürümez, Mustafa K
Klawonn, Frank
Ast, Volker
Gerhards, Catharina
Eichner, Romy
Costina, Victor
Dobler, Gerhard
Geilenkeuser, Wolf-Jochen
Wölfel, Roman
Neumaier, Michael
Issue Date
2020-08-27
Metadata
Show full item recordCitation
Clin Chem Lab Med. 2020;/j/cclm.ahead-of-print/cclm-2020-1183/cclm-2020-1183.xml. doi:10.1515/cclm-2020-1183.Affiliation
HZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.Publisher
DeGruyterPubMed ID
32853163Type
ArticleLanguage
enEISSN
1437-4331ae974a485f413a2113503eed53cd6c53
10.1515/cclm-2020-1183
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
Related articles
- Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection.
- Authors: Ast V, Costina V, Eichner R, Bode A, Aida S, Gerhards C, Thiaucourt M, Dobler G, Geilenkeuser WJ, Wölfel R, Neumaier M, Haselmann V
- Issue date: 2021 Aug 18
- Serological diagnostic for SARS-CoV-2: an experimental External Quality Assessment Scheme.
- Authors: Sciacovelli L, Padoan A, Secchiero S, Plebani M
- Issue date: 2021 Oct 26
- Results of a European-Wide External Quality Assessment (EQA) Scheme for Serological Detection of Anti-SARS-CoV-2 (CoVimm)-Pitfalls of Routine Application.
- Authors: Kittel M, Eichner R, Aida S, Bode A, Ast V, Kessler A, Neumaier M, Wölfel R, Haselmann V
- Issue date: 2022 Jul 28
- Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation.
- Authors: Jääskeläinen AJ, Kuivanen S, Kekäläinen E, Ahava MJ, Loginov R, Kallio-Kokko H, Vapalahti O, Jarva H, Kurkela S, Lappalainen M
- Issue date: 2020 Aug
- Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
- Authors: Nicol T, Lefeuvre C, Serri O, Pivert A, Joubaud F, Dubée V, Kouatchet A, Ducancelle A, Lunel-Fabiani F, Le Guillou-Guillemette H
- Issue date: 2020 Aug